U.K. Insurance Stock News

Ignoring the stock price of a company, what are the underlying trends that tell us a business is past the growth phase...

Key Insights Institutions' substantial holdings in 3i Group implies that they have significant influence over the...

The United Kingdom's stock market has recently faced challenges, with the FTSE 100 index declining due to weak trade data from China and falling commodity prices impacting major companies. As global economic pressures continue to influence market performance, identifying stocks trading below their fair value could present opportunities for investors seeking potential growth.

The UK stock market has recently faced challenges, with the FTSE 100 and FTSE 250 indices experiencing declines due to weak trade data from China, highlighting concerns over global economic recovery. In such uncertain times, growth companies with high insider ownership can offer a unique investment perspective as insiders' significant stakes often indicate confidence in the company's long-term potential despite broader market fluctuations.

The UK stock market has recently faced challenges, with the FTSE 100 index experiencing declines due to weak trade data from China, highlighting the interconnectedness of global economies. In such a climate, investors often seek opportunities in lesser-known areas like penny stocks—companies that may offer unique value and growth potential despite their smaller size or newer presence in the market. While the term 'penny stocks' might seem outdated, these investments can still be relevant when...

The United Kingdom's FTSE 100 index recently experienced a downturn, influenced by weak trade data from China, which has impacted companies with strong ties to the Chinese economy. Amidst these global uncertainties and market fluctuations, dividend stocks can offer investors a measure of stability and income through regular payouts, making them an attractive option during volatile times.

Key Insights The projected fair value for Convatec Group is UK£3.22 based on 2 Stage Free Cash Flow to Equity Current...

As the pan-European STOXX Europe 600 Index hit a new high, buoyed by an improving economic backdrop and closing 2025 with its strongest yearly performance since 2021, investor interest in small-cap stocks is rising. In this environment, identifying promising small-cap companies often involves examining those with solid fundamentals and notable insider activity, which can signal confidence from within the company amidst broader market optimism.

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

Key Insights Significantly high institutional ownership implies Eurasia Mining's stock price is sensitive to their...

Key Insights Given the large stake in the stock by institutions, Prudential's stock price might be vulnerable to their...

GSK stock: what recent performance says about investor interest GSK (LSE:GSK) has quietly attracted attention after a period of steady share price performance, with the stock showing positive returns over the past week, month and past 3 months. See our latest analysis for GSK. Zooming out, the share price sits at £18.32 and the 3 month share price return of 13.44% contrasts with a 1 year total shareholder return of 41.69%. This indicates momentum that has been building rather than fading. If...

Unilever (LSE:ULVR) has been quietly treading water, with the share price slipping about 4% over the past month yet still delivering solid gains over the past 3 years, which raises an interesting valuation question. See our latest analysis for Unilever. Over the past year, Unilever’s modest 1 year total shareholder return of 2.31%, alongside a slightly negative 90 day share price return, suggests momentum has cooled a bit even as management pushes through gradual, margin focused changes. If...

AstraZeneca (LSE:AZN) has quietly ground out solid gains over the past year, and today’s move is less about a flashy headline and more about how that trend stacks up against its fundamentals. See our latest analysis for AstraZeneca. The latest dip in AstraZeneca’s £135.92 share price comes after a strong run, with a 90 day share price return of 7.45% contributing to a 1 year total shareholder return of 31.08%, suggesting momentum is still broadly constructive. If AstraZeneca’s steady progress...

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'll want...

Investing in stocks inevitably means buying into some companies that perform poorly. But the long term shareholders of...

Made Tech Group Plc ( LON:MTEC ) shareholders are no doubt pleased to see that the share price has bounced 27% in the...

Softcat (LON:SCT) has had a rough three months with its share price down 12%. However, a closer look at its sound...

Ingenta plc ( LON:ING ) shares have continued their recent momentum with a 25% gain in the last month alone. Looking...

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

The Berkeley Group Holdings plc ( LON:BKG ), is not the largest company out there, but it received a lot of attention...